The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH/ISH 2016 | The main challenges facing practitioners treating APL
Eduardo Rego
• 18 Apr 2016
Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses the main challenges, primarily bleeding, practitioners face when treating acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). Most patients present severe bleeding, primarily intracranial bleeding. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
